Literature DB >> 17699193

Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?

Dennis Y Wu1, Christian S Shinaberger, Deborah L Regidor, Charles J McAllister, Joel D Kopple, Kamyar Kalantar-Zadeh.   

Abstract

The optimal acid-base status for survival in maintenance hemodialysis (MHD) patients remains controversial. According to recent reports, acidosis is associated with improved survival in MHD patients. It was hypothesized that this inverse association is due to a confounding effect of the malnutrition-inflammation complex syndrome (MICS). Associations between baseline (first 3 mo averaged) predialysis serum bicarbonate (HCO3(-)) and 2-yr mortality were examined in 56,385 MHD patients who were treated in virtually all DaVita dialysis clinics across the United States. The range of HCO3(-) was divided into 12 categories (< 17, > or = 27, and 10 groups in between). Three sets of Cox regression models were evaluated to estimate hazard ratios of all-cause and cardiovascular death in both incident and prevalent patients: (1) Unadjusted, (2) multivariate case mix adjusted (which also included dialysate HCO3(-) and Kt/V), and (3) adjusted for case mix and nine markers of MICS (body mass index; erythropoietin dose; protein intake; serum albumin; creatinine; phosphorus; calcium; ferritin and total iron binding capacity; and blood hemoglobin, WBC, and lymphocytes). There were significant inverse associations between serum HCO3(-) and serum phosphorus and estimated protein intake. The lowest unadjusted mortality was associated with predialysis HCO3(-) in the 17- to 23-mEq/L range, whereas values > or = 23 mEq/L were associated with progressively higher all-cause and cardiovascular death rates. This association, however, reversed after case-mix and MICS multivariate adjustment, so that HCO3(-) values >22 mEq/L had lower death risk. Although previous epidemiologic studies indicated an association between high serum HCO3(-) and increased mortality in MHD patients, this effect seems to be due substantially to the effect of MICS on survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17699193     DOI: 10.2215/CJN.00010505

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  49 in total

Review 1.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

Review 2.  Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrology (Carlton)       Date:  2009-06       Impact factor: 2.506

3.  Oral bicarbonate: renoprotective in CKD?

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2010-01       Impact factor: 28.314

4.  Protein carbamylation predicts mortality in ESRD.

Authors:  Robert A Koeth; Kamyar Kalantar-Zadeh; Zeneng Wang; Xiaoming Fu; W H Wilson Tang; Stanley L Hazen
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

Review 5.  Optimal nutrition in hemodialysis patients.

Authors:  T Alp Ikizler
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

Review 6.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

7.  Bicarbonate, blood pressure, and executive function in pediatric CKD-is there a link?

Authors:  Lyndsay A Harshman; Amy J Kogon; Matthew B Matheson; Rebecca J Johnson; Shlomo Shinnar; Arlene C Gerson; Bradley A Warady; Susan L Furth; Stephen R Hooper; Marc B Lande
Journal:  Pediatr Nephrol       Date:  2020-04-15       Impact factor: 3.714

8.  Case in Point: Correction of Dialysis-Induced Metabolic Alkalosis.

Authors:  Assad Mohammedzein; Tarek Naguib
Journal:  Fed Pract       Date:  2021-04

9.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

10.  Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Angelo Karaboyas; Bruce M Robinson; Hal Morgenstern; Jinyao Zhang; Ananda Sen; T Alp Ikizler; Hugh Rayner; Rachel B Fissell; Raymond Vanholder; Tadashi Tomo; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2013-05-24       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.